{"transactions":[{"id":900317,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2026-02-17T11:04:01.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":70008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on December 31, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile of ROIC (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile of ROIC (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on December 31, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":70008,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":70008},"source":{"system":"sec-edgar","filing":"0001193125-26-053598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000119312526053598/ownership.xml","form_type":"4"}},{"id":949930,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2026-01-05T15:17:09.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":61417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":61417},"source":{"system":"sec-edgar","filing":"0001193125-26-002252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000119312526002252/ownership.xml","form_type":"4"}},{"id":949929,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-01-05T15:17:09.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":true,"shares":61417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":142354,"source":{"system":"sec-edgar","filing":"0001193125-26-002252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000119312526002252/ownership.xml","form_type":"4"}},{"id":949928,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-01-05T15:17:09.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":32152,"price":16.03,"value":515396.56,"ownership":{"direct":true},"balance_after":110202,"source":{"system":"sec-edgar","filing":"0001193125-26-002252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000119312526002252/ownership.xml","form_type":"4"}},{"id":1269259,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2025-02-13T16:37:31.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on January 1, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile of ROIC (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile of ROIC (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half\nif absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at\nthe end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, on January 1, 2028, following the conclusion of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (\"ROIC\") among the Bloomberg Peer Group (\"BPG\"), 100% of the award will vest if the Company is in the top 55th percentile of ROIC among the BPG, and 175% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":68800,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":68800},"source":{"system":"sec-edgar","filing":"0000950170-25-019960","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017025019960/ownership.xml","form_type":"4"}},{"id":1313349,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2025-01-03T16:59:02.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":23607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2022, as disclosed in the Reporting Person's Form 4 filing on February 17, 2022.  The Company finished in the 52nd percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2024. Therefore, the performance criteria and requirements for vesting have been satisfied at 54.6% of the target award level, and such number of shares vested on December 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2022, as disclosed in the Reporting Person's Form 4 filing on February 17, 2022.  The Company finished in the 52nd percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2024. Therefore, the performance criteria and requirements for vesting have been satisfied at 54.6% of the target award level, and such number of shares vested on December 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23607},"source":{"system":"sec-edgar","filing":"0000950170-25-001317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017025001317/ownership.xml","form_type":"4"}},{"id":1313348,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2025-01-03T16:59:02.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":23607,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":95656,"source":{"system":"sec-edgar","filing":"0000950170-25-001317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017025001317/ownership.xml","form_type":"4"}},{"id":1313347,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2025-01-03T16:59:02.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14719,"price":17.31,"value":254785.89,"ownership":{"direct":true},"balance_after":80937,"source":{"system":"sec-edgar","filing":"0000950170-25-001317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017025001317/ownership.xml","form_type":"4"}},{"id":1640534,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2024-02-15T16:11:40.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":79442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period\nas follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period\nas follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award).\nThe number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":79442,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":79442},"source":{"system":"sec-edgar","filing":"0000950170-24-015888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017024015888/ownership.xml","form_type":"4"}},{"id":1683635,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2024-01-08T14:49:33.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14195,"price":17.66,"value":250683.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 13,870 shares.  The corrected transaction reflects an increase of 325 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person."}],"balance_after":72049,"source":{"system":"sec-edgar","filing":"0000950170-24-002890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017024002890/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-03"}},{"id":1690776,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2024-01-03T17:43:16.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":36072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021.  The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023.  Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half.  Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021.  The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023.  Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half.  Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36072},"source":{"system":"sec-edgar","filing":"0000950170-24-001237","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017024001237/ownership.xml","form_type":"4"}},{"id":1690775,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2024-01-03T17:43:16.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":36072,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":86244,"source":{"system":"sec-edgar","filing":"0000950170-24-001237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017024001237/ownership.xml","form_type":"4"}},{"id":1690774,"issuer":{"id":5382,"kind":"organization","name":"Core Laboratories Inc. /DE/","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2024-01-03T17:43:16.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":13870,"price":17.66,"value":244944.2,"ownership":{"direct":true},"balance_after":72374,"source":{"system":"sec-edgar","filing":"0000950170-24-001237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641315/000095017024001237/ownership.xml","form_type":"4"}},{"id":2004646,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2023-02-21T15:20:16.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":52718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":52718,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":52718},"source":{"system":"sec-edgar","filing":"0001209191-23-011099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123011099/doc4.xml","form_type":"4"}},{"id":2069777,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2023-01-04T16:55:50.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":31688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020.  All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020.  All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31688},"source":{"system":"sec-edgar","filing":"0001209191-23-001028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123001028/doc4.xml","form_type":"4"}},{"id":2069776,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2023-01-04T16:55:50.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":31688,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62642,"source":{"system":"sec-edgar","filing":"0001209191-23-001028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123001028/doc4.xml","form_type":"4"}},{"id":2069775,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2023-01-04T16:55:50.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":12470,"price":20.27,"value":252766.9,"ownership":{"direct":true},"balance_after":50172,"source":{"system":"sec-edgar","filing":"0001209191-23-001028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919123001028/doc4.xml","form_type":"4"}},{"id":2389556,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2022-02-17T17:08:43.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":43236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2022 and ends on December 31, 2024 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause, termination by the employee for \"good reason\" (as defined in the employee's employment agreement), or retirement by the employee upon having reached 62 years of age.  The shares would vest, if at all, at the end of the Performance Period as follows: (i) 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (\"BPG\"); (ii) 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG; or (iii) 150% of the award will vest if the Company is the top performing ROIC company of the BPG, all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Share Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2022 and ends on December 31, 2024 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause, termination by the employee for \"good reason\" (as defined in the employee's employment agreement), or retirement by the employee upon having reached 62 years of age.  The shares would vest, if at all, at the end of the Performance Period as follows: (i) 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (\"BPG\"); (ii) 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG; or (iii) 150% of the award will vest if the Company is the top performing ROIC company of the BPG, all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Share Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":43236,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":43236},"source":{"system":"sec-edgar","filing":"0001209191-22-010862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122010862/doc4.xml","form_type":"4"}},{"id":2451232,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2022-01-04T17:55:09.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":23529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vesting were awarded as restricted performance shares in February 2019 as reported in the Form 4 filing on February 14, 2019. This filing states that 50%  of the restricted performance shares will vest at the end of the Performance Period if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th ROIC percentile of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG. The Company was the top performing ROIC company as of the end of the performance period and as such the performance criteria and all requirements for full vesting have been met and thus the shares granted in February 2019 vested on December 31, 2021, at the conclusion of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares vesting were awarded as restricted performance shares in February 2019 as reported in the Form 4 filing on February 14, 2019. This filing states that 50%  of the restricted performance shares will vest at the end of the Performance Period if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th ROIC percentile of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG. The Company was the top performing ROIC company as of the end of the performance period and as such the performance criteria and all requirements for full vesting have been met and thus the shares granted in February 2019 vested on December 31, 2021, at the conclusion of the performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":23529},"source":{"system":"sec-edgar","filing":"0001209191-22-001068","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122001068/doc4.xml","form_type":"4"}},{"id":2451231,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2022-01-04T17:55:09.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":23529,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40213,"source":{"system":"sec-edgar","filing":"0001209191-22-001068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122001068/doc4.xml","form_type":"4"}},{"id":2451230,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2022-01-04T17:55:09.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":9259,"price":22.31,"value":206568.29,"ownership":{"direct":true},"balance_after":30954,"source":{"system":"sec-edgar","filing":"0001209191-22-001068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919122001068/doc4.xml","form_type":"4"}},{"id":2840659,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2021-02-23T16:42:38.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":33950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing ROIC company of the BPG all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Shareholder Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2021 and ends on December 31, 2023 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing ROIC company of the BPG all as measured and determined by the Compensation Committee at the end of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Shareholder Return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period."}],"balance_after":33950,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":33950},"source":{"system":"sec-edgar","filing":"0001209191-21-013240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121013240/doc4.xml","form_type":"4"}},{"id":2922581,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2021-01-05T16:21:02.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2018 and ended December 31, 2020 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2018 and ended December 31, 2020 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001209191-21-001047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121001047/doc4.xml","form_type":"4"}},{"id":2922580,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2021-01-05T16:21:02.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":1024,"price":26.51,"value":27146.24,"ownership":{"direct":true},"balance_after":16684,"source":{"system":"sec-edgar","filing":"0001209191-21-001047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121001047/doc4.xml","form_type":"4"}},{"id":2922579,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2021-01-05T16:21:02.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17708,"source":{"system":"sec-edgar","filing":"0001209191-21-001047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919121001047/doc4.xml","form_type":"4"}},{"id":3187396,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Shares","published_at":"2020-04-02T14:56:03.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001209191-20-022444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120022444/doc4.xml","form_type":"4"}},{"id":3187395,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2020-04-02T14:56:03.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":24,"price":9.49,"value":227.76,"ownership":{"direct":true},"balance_after":15108,"source":{"system":"sec-edgar","filing":"0001209191-20-022444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120022444/doc4.xml","form_type":"4"}},{"id":3187394,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2020-04-02T14:56:03.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15132,"source":{"system":"sec-edgar","filing":"0001209191-20-022444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120022444/doc4.xml","form_type":"4"}},{"id":3277938,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2020-02-12T17:22:19.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":31688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2020 and ends on December 31, 2022 (the\n\"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or\nretirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as\nfollows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer\nGroup (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the\nCompany is the top performing ROIC company of the BPG."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Shareholder Return for the 2020 Performance Period is negative, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If the minimum performance criteria is not met, then no shares shall vest and the award shall be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2020 and ends on December 31, 2022 (the\n\"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or\nretirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as\nfollows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer\nGroup (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the\nCompany is the top performing ROIC company of the BPG."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These awards will be interpolated on a straight-line basis from the 50th percentile to the 100th percentile. The amount that vests over the 100% of the award up to the maximum 150% of the award, if any, is subject to a reduction of one-half of the final percentage above 100% if absolute Total Shareholder Return for the 2020 Performance Period is negative, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If the minimum performance criteria is not met, then no shares shall vest and the award shall be forfeited."}],"balance_after":31688,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31688},"source":{"system":"sec-edgar","filing":"0001209191-20-008888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120008888/doc4.xml","form_type":"4"}},{"id":3324421,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Performance Shares","published_at":"2020-01-03T16:09:03.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2017 and ended December 31, 2019 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2017 and ended December 31, 2019 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001209191-20-000804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120000804/doc4.xml","form_type":"4"}},{"id":3324420,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2020-01-03T16:09:03.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":945,"price":37.67,"value":35598.15,"ownership":{"direct":true},"balance_after":15079,"source":{"system":"sec-edgar","filing":"0001209191-20-000804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120000804/doc4.xml","form_type":"4"}},{"id":3324419,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Shares","published_at":"2020-01-03T16:09:03.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16024,"source":{"system":"sec-edgar","filing":"0001209191-20-000804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000120919120000804/doc4.xml","form_type":"4"}},{"id":3569944,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Shares","published_at":"2019-04-02T16:10:26.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."}],"balance_after":53,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001000229-19-000048","document":"wf-form4_155423581124804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000048/wf-form4_155423581124804.xml","form_type":"4"}},{"id":3569943,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Shares","published_at":"2019-04-02T16:10:26.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":25,"price":68.93,"value":1723.25,"ownership":{"direct":true},"balance_after":13624,"source":{"system":"sec-edgar","filing":"0001000229-19-000048","document":"wf-form4_155423581124804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000048/wf-form4_155423581124804.xml","form_type":"4"}},{"id":3569942,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Shares","published_at":"2019-04-02T16:10:26.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13649,"source":{"system":"sec-edgar","filing":"0001000229-19-000048","document":"wf-form4_155423581124804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000048/wf-form4_155423581124804.xml","form_type":"4"}},{"id":3615164,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Shares","published_at":"2019-03-05T16:18:53.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."}],"balance_after":106,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001000229-19-000029","document":"wf-form4_155182071943198.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000029/wf-form4_155182071943198.xml","form_type":"4"}},{"id":3615163,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Shares","published_at":"2019-03-05T16:18:53.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":46,"price":67.37,"value":3099.02,"ownership":{"direct":true},"balance_after":13596,"source":{"system":"sec-edgar","filing":"0001000229-19-000029","document":"wf-form4_155182071943198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000029/wf-form4_155182071943198.xml","form_type":"4"}},{"id":3615162,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Shares","published_at":"2019-03-05T16:18:53.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13642,"source":{"system":"sec-edgar","filing":"0001000229-19-000029","document":"wf-form4_155182071943198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000029/wf-form4_155182071943198.xml","form_type":"4"}},{"id":3657780,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Performance Shares","published_at":"2019-02-14T16:26:39.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":15684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2019 and ends on December 31, 2021 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If the minimum performance criteria is not met, then no shares shall vest and the award shall be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests at the end of a three-year performance period that began on January 1, 2019 and ends on December 31, 2021 (the \"Performance Period\"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 64 years of age. In all cases, the shares will vest at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If the minimum performance criteria is not met, then no shares shall vest and the award shall be forfeited."}],"balance_after":15684,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15684},"source":{"system":"sec-edgar","filing":"0001000229-19-000026","document":"wf-form4_155017958545108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000026/wf-form4_155017958545108.xml","form_type":"4"}},{"id":3710353,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Performance Shares","published_at":"2019-01-03T16:16:35.000Z","date":"2018-12-31","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2016 and ended on December 31, 2018 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These awards vested at the end of a three-year performance period that began on January 1, 2016 and ended on December 31, 2018 (the \"Performance Period\"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001000229-19-000006","document":"wf-form4_154655016149671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000006/wf-form4_154655016149671.xml","form_type":"4"}},{"id":3710352,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Shares","published_at":"2019-01-03T16:16:35.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":1181,"price":59.66,"value":70458.46,"ownership":{"direct":true},"balance_after":13542,"source":{"system":"sec-edgar","filing":"0001000229-19-000006","document":"wf-form4_154655016149671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000006/wf-form4_154655016149671.xml","form_type":"4"}},{"id":3710351,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Shares","published_at":"2019-01-03T16:16:35.000Z","date":"2018-12-31","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14723,"source":{"system":"sec-edgar","filing":"0001000229-19-000006","document":"wf-form4_154655016149671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022919000006/wf-form4_154655016149671.xml","form_type":"4"}},{"id":3826047,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Restricted Shares","published_at":"2018-09-05T17:17:00.000Z","date":"2018-09-01","kind":"exercise","acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":206,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001000229-18-000106","document":"wf-form4_153618220338931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000106/wf-form4_153618220338931.xml","form_type":"4"}},{"id":3826046,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Shares","published_at":"2018-09-05T17:17:00.000Z","date":"2018-09-01","kind":"tax_withholding","acquired":false,"shares":49,"price":114.55,"value":5612.95,"ownership":{"direct":true},"balance_after":11723,"source":{"system":"sec-edgar","filing":"0001000229-18-000106","document":"wf-form4_153618220338931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000106/wf-form4_153618220338931.xml","form_type":"4"}},{"id":3826045,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Shares","published_at":"2018-09-05T17:17:00.000Z","date":"2018-09-01","kind":"exercise","acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11772,"source":{"system":"sec-edgar","filing":"0001000229-18-000106","document":"wf-form4_153618220338931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000106/wf-form4_153618220338931.xml","form_type":"4"}},{"id":3974343,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2018-04-03T17:27:56.000Z","date":"2018-04-01","kind":"exercise","acquired":false,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":331,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001000229-18-000056","document":"wf-form4_152279084158042.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000056/wf-form4_152279084158042.xml","form_type":"4"}},{"id":3974342,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-04-03T17:27:56.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":16,"price":108.22,"value":1731.52,"ownership":{"direct":true},"balance_after":11647,"source":{"system":"sec-edgar","filing":"0001000229-18-000056","document":"wf-form4_152279084158042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000056/wf-form4_152279084158042.xml","form_type":"4"}},{"id":3974341,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-04-03T17:27:56.000Z","date":"2018-04-01","kind":"exercise","acquired":true,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11663,"source":{"system":"sec-edgar","filing":"0001000229-18-000056","document":"wf-form4_152279084158042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000056/wf-form4_152279084158042.xml","form_type":"4"}},{"id":4004103,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2018-03-09T18:33:58.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":384,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001000229-18-000039","document":"wf-form4_152063842416905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000039/wf-form4_152063842416905.xml","form_type":"4"}},{"id":4004102,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-03-09T18:33:58.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":30,"price":102.99,"value":3089.7,"ownership":{"direct":true},"balance_after":11610,"source":{"system":"sec-edgar","filing":"0001000229-18-000039","document":"wf-form4_152063842416905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000039/wf-form4_152063842416905.xml","form_type":"4"}},{"id":4004101,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-03-09T18:33:58.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11640,"source":{"system":"sec-edgar","filing":"0001000229-18-000039","document":"wf-form4_152063842416905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000039/wf-form4_152063842416905.xml","form_type":"4"}},{"id":4055895,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Shares","published_at":"2018-02-15T18:00:40.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a three-year performance period that begins on January 1, 2018 and ends on the last NYSE trading day of December 2020 (the \"Performance Period\"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a three-year performance period that begins on January 1, 2018 and ends on the last NYSE trading day of December 2020 (the \"Performance Period\"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award be forfeited."}],"balance_after":2600,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001000229-18-000035","document":"wf-form4_151873562535853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000035/wf-form4_151873562535853.xml","form_type":"4"}},{"id":4113996,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Shares","published_at":"2018-01-03T18:08:45.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vesting were awarded as restricted performance shares in May 2015. As reported in the Form 4 filing on May 7, 2015 at the time the award was made, \"The restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period and the shares shall fully vest if that criterion is met. If it is not met, then no shares shall vest and the award shall be forfeited.\" The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 29, 2017, at the conclusion of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares vesting were awarded as restricted performance shares in May 2015. As reported in the Form 4 filing on May 7, 2015 at the time the award was made, \"The restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period and the shares shall fully vest if that criterion is met. If it is not met, then no shares shall vest and the award shall be forfeited.\" The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 29, 2017, at the conclusion of the performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001000229-18-000015","document":"wf-form4_151502091107612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000015/wf-form4_151502091107612.xml","form_type":"4"}},{"id":4113995,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-01-03T18:08:45.000Z","date":"2017-12-29","kind":"tax_withholding","acquired":false,"shares":821,"price":109.55,"value":89940.55,"ownership":{"direct":true},"balance_after":11540,"source":{"system":"sec-edgar","filing":"0001000229-18-000015","document":"wf-form4_151502091107612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000015/wf-form4_151502091107612.xml","form_type":"4"}},{"id":4113994,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2018-01-03T18:08:45.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12361,"source":{"system":"sec-edgar","filing":"0001000229-18-000015","document":"wf-form4_151502091107612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022918000015/wf-form4_151502091107612.xml","form_type":"4"}},{"id":4143056,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2017-12-05T17:53:51.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":484,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001000229-17-000095","document":"wf-form4_151251441879968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000095/wf-form4_151251441879968.xml","form_type":"4"}},{"id":4143055,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-12-05T17:53:51.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":35,"price":105.04,"value":3676.4,"ownership":{"direct":true},"balance_after":9361,"source":{"system":"sec-edgar","filing":"0001000229-17-000095","document":"wf-form4_151251441879968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000095/wf-form4_151251441879968.xml","form_type":"4"}},{"id":4143054,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-12-05T17:53:51.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9396,"source":{"system":"sec-edgar","filing":"0001000229-17-000095","document":"wf-form4_151251441879968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000095/wf-form4_151251441879968.xml","form_type":"4"}},{"id":4218527,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2017-09-05T16:08:31.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":609,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001000229-17-000081","document":"wf-form4_150464209821732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000081/wf-form4_150464209821732.xml","form_type":"4"}},{"id":4218526,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-09-05T16:08:31.000Z","date":"2017-09-01","kind":"tax_withholding","acquired":false,"shares":35,"price":89.59,"value":3135.65,"ownership":{"direct":true},"balance_after":9271,"source":{"system":"sec-edgar","filing":"0001000229-17-000081","document":"wf-form4_150464209821732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000081/wf-form4_150464209821732.xml","form_type":"4"}},{"id":4218525,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-09-05T16:08:31.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9306,"source":{"system":"sec-edgar","filing":"0001000229-17-000081","document":"wf-form4_150464209821732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000081/wf-form4_150464209821732.xml","form_type":"4"}},{"id":4358950,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2017-04-05T09:06:53.000Z","date":"2017-04-01","kind":"exercise","acquired":false,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."}],"balance_after":734,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001000229-17-000054","document":"wf-form4_149139759858098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000054/wf-form4_149139759858098.xml","form_type":"4"}},{"id":4358949,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-04-05T09:06:53.000Z","date":"2017-04-01","kind":"tax_withholding","acquired":false,"shares":18,"price":115.52,"value":2079.36,"ownership":{"direct":true},"balance_after":9181,"source":{"system":"sec-edgar","filing":"0001000229-17-000054","document":"wf-form4_149139759858098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000054/wf-form4_149139759858098.xml","form_type":"4"}},{"id":4358948,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-04-05T09:06:53.000Z","date":"2017-04-01","kind":"exercise","acquired":true,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9199,"source":{"system":"sec-edgar","filing":"0001000229-17-000054","document":"wf-form4_149139759858098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000054/wf-form4_149139759858098.xml","form_type":"4"}},{"id":4405954,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2017-03-03T16:54:55.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Multiple restricted share grants are included in this total."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":787,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001000229-17-000038","document":"wf-form4_148857808127037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000038/wf-form4_148857808127037.xml","form_type":"4"}},{"id":4405953,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-03-03T16:54:55.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":33,"price":118.74,"value":3918.42,"ownership":{"direct":true},"balance_after":9146,"source":{"system":"sec-edgar","filing":"0001000229-17-000038","document":"wf-form4_148857808127037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000038/wf-form4_148857808127037.xml","form_type":"4"}},{"id":4405952,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2017-03-03T16:54:55.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9179,"source":{"system":"sec-edgar","filing":"0001000229-17-000038","document":"wf-form4_148857808127037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000038/wf-form4_148857808127037.xml","form_type":"4"}},{"id":4443540,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Performance Shares","published_at":"2017-02-16T16:56:28.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a three-year performance period that began on January 1, 2017 and ends on the last NYSE trading day of December 2019 (the \"Performance Period\"). At the end of the Performance Period, these restricted performance shares will vest only if the Company's return on invested capital (ROIC) is in the top 75th percentile of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period. If that criterion is met, the awards shall fully vest and if that criterion is not met, then no shares shall vest and the award shall be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a three-year performance period that began on January 1, 2017 and ends on the last NYSE trading day of December 2019 (the \"Performance Period\"). At the end of the Performance Period, these restricted performance shares will vest only if the Company's return on invested capital (ROIC) is in the top 75th percentile of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period. If that criterion is met, the awards shall fully vest and if that criterion is not met, then no shares shall vest and the award shall be forfeited."}],"balance_after":2400,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001000229-17-000031","document":"wf-form4_148728217063569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022917000031/wf-form4_148728217063569.xml","form_type":"4"}},{"id":4533969,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2016-12-05T16:05:14.000Z","date":"2016-12-01","kind":"exercise","acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":887,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":125},"source":{"system":"sec-edgar","filing":"0001000229-16-000224","document":"wf-form4_148097190098868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000224/wf-form4_148097190098868.xml","form_type":"4"}},{"id":4533968,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2016-12-05T16:05:14.000Z","date":"2016-12-01","kind":"tax_withholding","acquired":false,"shares":35,"price":116.14,"value":4064.9,"ownership":{"direct":true},"balance_after":9079,"source":{"system":"sec-edgar","filing":"0001000229-16-000224","document":"wf-form4_148097190098868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000224/wf-form4_148097190098868.xml","form_type":"4"}},{"id":4533967,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2016-12-05T16:05:14.000Z","date":"2016-12-01","kind":"exercise","acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9114,"source":{"system":"sec-edgar","filing":"0001000229-16-000224","document":"wf-form4_148097190098868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000224/wf-form4_148097190098868.xml","form_type":"4"}},{"id":4590765,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Shares","published_at":"2016-10-03T16:18:50.000Z","date":"2016-10-01","kind":"exercise","acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Multiple restricted share grants are included in this total."}],"balance_after":1012,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":150},"source":{"system":"sec-edgar","filing":"0001000229-16-000211","document":"wf-form4_147552591785854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000211/wf-form4_147552591785854.xml","form_type":"4"}},{"id":4590764,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2016-10-03T16:18:50.000Z","date":"2016-10-01","kind":"tax_withholding","acquired":false,"shares":42,"price":112.33,"value":4717.86,"ownership":{"direct":true},"balance_after":8989,"source":{"system":"sec-edgar","filing":"0001000229-16-000211","document":"wf-form4_147552591785854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000211/wf-form4_147552591785854.xml","form_type":"4"}},{"id":4590763,"issuer":{"id":11862,"kind":"organization","name":"CORE LABORATORIES N V","symbol":"CLB"},"owners":[{"id":66149,"kind":"person","name":"Hill Christopher Scott","position":1,"cik":"0001641315","reported_name":"Hill Christopher Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2016-10-03T16:18:50.000Z","date":"2016-10-01","kind":"exercise","acquired":true,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9031,"source":{"system":"sec-edgar","filing":"0001000229-16-000211","document":"wf-form4_147552591785854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000229/000100022916000211/wf-form4_147552591785854.xml","form_type":"4"}}]}